Incidence and impact of activating mutations of the RAS-RAF- MEK-ERK pathway in patients with philadelphia-negative (Ph-negative) myeloproliferative neoplasms (MPNs) and myelodysplastic/myeloproliferative disorders-unclassified (MDS/MPD-U)
Loading...
External sources
External sources
Date
Advisor
Coadvisor
Graduate program
Undergraduate course
Journal Title
Journal ISSN
Volume Title
Publisher
Amer Soc Hematology
Type
Abstract
Access right
Acesso aberto
External sources
External sources
Abstract
Description
Keywords
Language
English
Citation
Blood. Washington: Amer Soc Hematology, v. 124, n. 21, p. 1-4, 2014.
